UNSPSC 41202013: Corynebacterium spp. serological reagents

In this classification, Corynebacterium genus serological reagents are devices used in test to identify specific Corynebacterium genus antibodies in serum. US FDA regulates Corynebacterium genus serological reagents under 21 CFR 866.3140 and under FDA product code KFI.

UNSPSC 41202013 Corynebacterium spp. serological reagents is a Commodity code that in recent state and local procurement activity encompasses HIV and Syphilis testing reagents, screening assays, diagnostic laboratory services, and related serology testing supplies. State and local governments are buying these materials to support public health surveillance, criminal justice drug-testing programs, and diagnostic laboratory operations. The issuing bodies are state health departments, county corrections and supervision departments, municipal health programs, and public universities. The Illinois Department of Public Health, Texas Department of Criminal Justice, and Collin County Community Supervision and Corrections Department appear as repeat buyers over the past few months. Most solicitations are structured as requests for proposal, invitations for bid, or emergency sole-source procurements tied to existing analyzer infrastructure (particularly Abbott ARCHITECT systems) or standing public health testing missions.

Recent opportunities span Texas and Illinois, with secondary activity in Florida and other states. The Illinois Department of Public Health issued an Invitation for Bid (IFB) on February 13, 2026, due March 16, 2026, for a five-year contract with renewal options to supply Hepatitis B and C antigen or antibody, HIV-1/HIV-2 antigen and antibody, and Syphilis antibody screening assays with fully automated instrumentation capable of handling approximately 40,000 tests annually; the contract requires no equipment cost to IDPH with all hardware, maintenance, and reagent pricing bundled. Collin County Community Supervision and Corrections Department issued an RFP (2026-327) due July 23, 2026, for offender specimen collection and drug testing services, including immunoassay screening and LC/MS/MS or GC/MS confirmation, with an estimated contract value of $600,000 over two years and three optional one-year renewals. The City of Austin issued an IFB (IFB9100AAM1023) due July 17, 2026, for rapid HIV test kits to support the Austin Public Health Program, with pricing on a per-unit basis and optional small business preference eligibility. The Illinois Department of Public Health also conducted emergency sole-source procurements with Abbott Laboratories Inc. for HIV and Syphilis reagents and related supplies in February and May 2026, with contract values of $38,079.50, reflecting the proprietary and regulated nature of specialized analyzer consumables.